Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 284 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Completed

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

NCT03953235

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +26 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Santa Monica, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • University of Chicago Medicine, Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details
Completed

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

NCT00161213

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • CentraState Medical Center Freehold, New Jersey, United States
  • Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States
  • Jersey Shore Cancer Center at Jersey Shore University Medical Center Neptune City, New Jersey, United States
View Trial Details
Completed

AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

NCT00265876

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada
  • Algoma District Cancer Program Sault Ste. Marie, Ontario, Canada
  • Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details

Related conditions